Selcia Radiolabelling is the partner of choice for carbon-14 radiosynthesis worldwide. We offer a level of personal service and dedication equivalent to an internal isotope laboratory, taking care of your all your radiolabelling needs or supporting internal groups in times of peak demand.

Selcia Discovery has significant research partnerships with leading pharmaceutical and biotechnology companies. We specialise in fragment based drug discovery and providing medicinal chemistry to support academic institutions and small biotech companies. We continue to seek partnerships with major companies for drug discovery projects in all therapeutic areas.

Both divisions are supported by our GLP MHRA accredited laboratory where our analysts, experienced in structural biology, structural elucidation and impurity profiling operate with exceptional infrastructure including three high-field NMR spectrometers to ensure the quality of your services.